SCHEMBL20072374

SCHEMBL20072374

CSSCc1ccc(N)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
CYP3A4 P08684 2/20 0.46
GFER P55789 1/20 0.46
TSHR P16473 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
LOXL2 Q9Y4K0 1/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
MAOB P27338 4/20 0.39
MAOA P21397 2/20 0.39
NOS1 P29475 1/20 0.39
MAPT P10636 2/20 0.38
IDO1 P14902 4/20 0.38
ACHE P22303 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3241999 0.85 ALDH1A1 (0.55) ALDH1A1CYP3A4GFERTSHRTDP1
SCHEMBL9976791 0.80 ALDH1A1 (0.50) ALDH1A1CYP3A4GFERTSHRTDP1
SCHEMBL514209 0.80 ALDH1A1 (0.50) ALDH1A1CYP3A4GFERTSHRTDP1
SCHEMBL777661 0.76 IDO1 (0.47) ALDH1A1TDP1LOXL2NPC1RAB9A
SCHEMBL9976775 0.76 ACHE (0.54) ALDH1A1CYP3A4GFERTSHRTDP1
SCHEMBL576610 0.75 TP53 (0.43) ALDH1A1CYP3A4TSHRMAOBNOS1
SCHEMBL3244307 0.74 ALDH1A1 (0.55) ALDH1A1CYP3A4GFERTSHRTDP1
SCHEMBL28866770 0.72 ALDH1A1 (0.52) ALDH1A1CYP3A4GFERTSHRTDP1
SCHEMBL18893321 0.71 CYP1A2 (0.73) ALDH1A1CYP3A4LOXL2MEN1KMT2A
SCHEMBL24215257 0.71 IDO1 (0.52) ALDH1A1MAOBMAPTIDO1ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11225469-B2 Inhibitors of phosphoglycerate dehydrogenase (PHGDH) and uses thereof WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2022-01-18 US disclosed
US-20180105508-A1 INHIBITORS OF PHOSPHOGLYCERATE DEHYDROGENASE (PHGDH) AND USES THEREOF WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2018-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11225469-B2 Inhibitors of phosphoglycerate dehydrogenase (PHGDH) and uses thereof PHGDH, PGD, PGK1 ALDH1A1 819/4885CYP3A4 1161/4885GFER 2899/4885
US-20180105508-A1 INHIBITORS OF PHOSPHOGLYCERATE DEHYDROGENASE (PHGDH) AND USES THEREOF PHGDH, PGD, PGK1 ALDH1A1 778/4885CYP3A4 1314/4885GFER 2931/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.